Concepedia
Statistics
Publications
9
Citations
419
H-Index
Active since
2014
Affiliations
University of Manchester(Current)
The Christie NHS Foundation Trust
South Tees Hospitals NHS Foundation Trust
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori
Fondazione IRCCS Istituto Nazionale dei Tumori
Laura Cove-Smith is an author at University of Manchester specializing in oncology, medicine, and chemotherapy.
Publications per year
2014–2025
Durvalumab After Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: The Phase 2 PACIFIC-6 Trial
Marina Chiara Garassino, Julien Mazières, Martin Reck et al. · Journal of Thoracic Oncology · 2022 · 123 citations · Full text
Medicine, Oncology, Pharmacotherapy +14
Extended pleurectomy decortication and chemotherapy versus chemotherapy alone for pleural mesothelioma (MARS 2): a phase 3 randomised controlled trial
Eric Lim, David Waller, Kelvin Lau et al. · The Lancet Respiratory Medicine · 2024 · 119 citations · Full text
Medicine, Oncology, Surgery +14
An Integrated Characterization of Serological, Pathological, and Functional Events in Doxorubicin-Induced Cardiotoxicity
Laura Cove-Smith, Neil Woodhouse, Adam Hargreaves et al. · Toxicological Sciences · 2014 · 58 citations
Medicine, Pharmacology, Toxicology +17
Toxic epidermal necrolysis (TEN) associated with the use of nivolumab (PD-1 inhibitor) for lymphoma
Liezel Griffin, Laura Cove-Smith, Hana Alachkar et al. · JAAD Case Reports · 2018 · 50 citations · Full text
Life Sciences, Immunology, Oncology +17
Durvalumab after sequential chemoradiotherapy in unresectable stage III non-small-cell lung cancer—final analysis from the phase II PACIFIC-6 trial
Marina Chiara Garassino, Jonathan Khalifa, Martin Reck et al. · ESMO Open · 2025 · 19 citations · Full text
Medicine, Oncology, Pharmacotherapy +17
1–5 of 9